summary
Introduced
01/28/2025
01/28/2025
In Committee
05/09/2025
05/09/2025
Crossed Over
Passed
Dead
Introduced Session
104th General Assembly
Bill Summary
Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude.
AI Summary
This bill amends the Prior Authorization Reform Act to prevent health insurance issuers from requiring prior authorization (a process where patients must get approval from their insurance before receiving certain medications) in several specific scenarios. Specifically, insurers cannot require prior authorization for prescription drugs that have been prescribed to a patient for 6 or more consecutive months, regardless of whether the medication is a non-preferred drug. Additionally, the bill prohibits prior authorization for several specific types of medications, including insulin, HIV prevention and treatment medications, viral hepatitis medications, hormonal medications (estrogen and progesterone), and specific drugs like Truvada, Harvoni, Descovy, and Apretude. By eliminating prior authorization requirements, the bill aims to reduce administrative barriers that might prevent patients from accessing necessary medications, particularly for chronic conditions and critical treatments related to HIV prevention and management.
Committee Categories
Business and Industry
Sponsors (2)
Last Action
Rule 3-9(a) / Re-referred to Assignments (on 05/09/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.ilga.gov/legislation/BillStatus.asp?DocNum=1258&GAID=18&DocTypeID=SB&SessionID=114&GA=104 |
| BillText | https://www.ilga.gov/legislation/104/SB/10400SB1258.htm |
Loading...